On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

Froedtert Hospital

InstitutionResearch output, impact & collaborations

Froedtert Hospital is a institution indexed in ScholarIQ from OpenAlex.

What is known about Froedtert Hospital?

ScholarIQrecord summary

Froedtert Hospital is a research organisation in Milwaukee, US. OpenAlex records 3,039 works and 149,708 citations for it. 938 researchers list it as their most recent affiliation.

How many works does Froedtert Hospital have?

ScholarIQindexed works

Froedtert Hospital has 3,039 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Froedtert Hospital →

How many citations does Froedtert Hospital have?

ScholarIQcitation count

Froedtert Hospital has 149,708 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Froedtert Hospital →

How many researchers are at Froedtert Hospital?

ScholarIQresearcher count

Froedtert Hospital has 938 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Froedtert Hospital?

ScholarIQavg h-index

Froedtert Hospital has an average h-index of 69.3 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Froedtert Hospital?

ScholarIQror

The ROR for Froedtert Hospital is on the source record.

Open the ROR →

What is the OpenAlex record for Froedtert Hospital?

ScholarIQopenalex

The OpenAlex for Froedtert Hospital is on the source record.

Open the OpenAlex →

What is the Wikidata of Froedtert Hospital?

ScholarIQwikidata

The Wikidata for Froedtert Hospital is on the source record.

Open the Wikidata →

Who are the most-cited researchers behind Froedtert Hospital?

ScholarIQtop researchers by citations

Razelle Kurzrock · Cancer Genomics and Diagnostics

2,331 works89,112 citations

Marc DeMoya · Trauma, Hemostasis, Coagulopathy, Resuscitation

126 works4,084 citations

Andrew E. Petroll · HIV/AIDS Research and Interventions

72 works2,151 citations

What are the most-cited papers on Froedtert Hospital?

ScholarIQmost cited works

Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers

Aaron M. Goodman, Shumei Kato, Lyudmila Bazhenova, Sandip Pravin Patel, Garrett M. Frampton, Vincent A. Miller, Philip J. Stephens, Gregory A. Daniels, Razelle Kurzrock

Molecular Cancer Therapeutics. 20172,408 CitationsOPEN ACCESS

PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy

Sandip Pravin Patel, Razelle Kurzrock

Molecular Cancer Therapeutics. 20152,356 Citations

International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease

David C. Fajgenbaum, Thomas S. Uldrick, Adam Bagg, Dale Frank, David Wu, Gordan Srkalović, David Simpson, Amy Liu, David M. Menke, Shanmuganathan Chandrakasan, Mary Jo Lechowicz, Raymond Wong, Sheila K. Pierson, Michele Paessler, Jean‐François Rossi, Makoto Ide, Jason R. Ruth, M.P. Croglio, Alexander Suarez, Vera P. Krymskaya, Amy Chadburn, Gisele W. B. Colleoni, Sunita D. Nasta, Raj Jayanthan, Christopher S. Nabel, Corey Casper, Angela Dispenzieri, Alexander Fosså, Dermot Kelleher, Razelle Kurzrock, Peter M. Voorhees, Ahmet Doǧan, Kazuyuki Yoshizaki, Frits van Rhee, Éric Oksenhendler, Elaine S. Jaffe, Kojo S.J. Elenitoba‐Johnson, Megan S. Lim

Blood. 2017633 CitationsOPEN ACCESS

Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial

Jordi Rodón, Jean‐Charles Soria, Raanan Berger, Wilson H. Miller, Eitan Rubin, Aleksandra Kugel, Apostolia M. Tsimberidou, Pierre Saintigny, Aliza Ackerstein, Irene Braña, Yohann Loriot, Mohammad Afshar, Vincent A. Miller, Fanny Wunder, Catherine Bresson, Jean-François Martini, Jacques Raynaud, John Mendelsohn, Gerald Batist, Amir Onn, Josep Tabernero, Richard L. Schilsky, Vladimir Lazar, J. Jack Lee, Razelle Kurzrock

Nature Medicine. 2019603 CitationsOPEN ACCESS

Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial

Jeffrey R. Infante, Leslie A. Fecher, Gerald S. Falchook, Sujatha Nallapareddy, Michael S. Gordon, Carlos Becerra, Douglas J. DeMarini, Donna S. Cox, Yanmei Xu, Shannon R. Morris, Vijay Peddareddigari, Ngocdiep T. Le, Lowell L. Hart, Johanna C. Bendell, Gail Eckhardt, Razelle Kurzrock, Keith T. Flaherty, Howard A. Burris, Wells A. Messersmith

The Lancet Oncology. 2012559 Citations

How much of the research on Froedtert Hospital is open access?

ScholarIQopen access share

83%OPEN ACCESS

Gold

Green

42%

Hybrid

Bronze

42%

Closed

17%